Intuitive Surgical, Inc. Share Price Sao Paulo

Equities

I1SR34

BRI1SRBDR001

Advanced Medical Equipment & Technology

Market Closed - Sao Paulo 12:59:31 15/06/2024 am IST 5-day change 1st Jan Change
114.4 BRL +0.47% Intraday chart for Intuitive Surgical, Inc. +3.24% +39.83%

Financials

Sales 2024 * 8.03B 43.16B 671B Sales 2025 * 9.33B 50.13B 779B Capitalization 151B 812B 12,613B
Net income 2024 * 1.97B 10.57B 164B Net income 2025 * 2.27B 12.22B 190B EV / Sales 2024 * 18.2 x
Net cash position 2024 * 5.19B 27.92B 434B Net cash position 2025 * 7.75B 41.68B 647B EV / Sales 2025 * 15.4 x
P/E ratio 2024 *
77.8 x
P/E ratio 2025 *
67.2 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.47%
1 week+3.24%
Current month+9.33%
1 month+12.06%
3 months+16.83%
6 months+43.15%
Current year+39.83%
More quotes
1 week
112.45
Extreme 112.45
115.19
1 month
101.80
Extreme 101.8
115.19
Current year
78.87
Extreme 78.87
115.19
1 year
64.37
Extreme 64.37
115.19
3 years
48.02
Extreme 48.02
116.15
5 years
39.21
Extreme 39.2083
116.15
10 years
39.21
Extreme 39.2083
116.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 01/96/01
President 56 01/96/01
Director of Finance/CFO 52 01/13/01
Members of the board TitleAgeSince
Director/Board Member 65 01/17/01
Director/Board Member 66 19/07/19
Director/Board Member 71 01/10/01
More insiders
Date Price Change Volume
14/24/14 114.4 +0.47% 538
13/24/13 113.9 -0.90% 1
12/24/12 114.9 +2.21% 9,665
11/24/11 112.4 +0.46% 36
10/24/10 111.9 +0.99% 2,936

Delayed Quote Sao Paulo, June 15, 2024 at 12:59 am IST

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
425.8 USD
Average target price
423.6 USD
Spread / Average Target
-0.52%
Consensus